Halstead Michael's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Nov 14, 2023
- Accession no.
- 0001209191-23-055207
- Filed
- Nov 14, 2023
- Trade date
- Nov 13, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.69M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Halstead MichaelCIK 0001521548 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Common Stock | MOption exerciseAcquired | +15,164 | $15.47 | +$234,587.08 | 15,164 | Direct | |
| Nov 13, 2023 | Common Stock | MOption exerciseAcquired | +34,836 | $12.73 | +$443,462.28 | 50,000 | Direct | |
| Nov 13, 2023 | Common Stock | SSaleDisposed | −8,933 | $53.37 | −$476,754.21 | 41,067 | Direct | |
| Nov 13, 2023 | Common Stock | SSaleDisposed | −41,067 | $54.01 | −$2,218,028.67 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Common Stock | MOption exerciseDisposed | −15,164 | $0.00 | $0 | 0 | Direct | |
| Nov 13, 2023 | Common Stock | MOption exerciseDisposed | −34,836 | $0.00 | $0 | 46,115 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.